Your browser doesn't support javascript.
loading
A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia.
Meltzer, H Y; Lindenmayer, J-P; Kwentus, J; Share, D B; Johnson, R; Jayathilake, K.
Afiliação
  • Meltzer HY; Northwestern Feinberg School of Medicine, Chicago, IL, United States. Electronic address: h-meltzer@northwestern.edu.
  • Lindenmayer JP; New York University School of Medicine, New York, NY, United States.
  • Kwentus J; Precise Research Center, Jackson, MS, United States.
  • Share DB; Northwestern Feinberg School of Medicine, Chicago, IL, United States.
  • Johnson R; Northwestern Feinberg School of Medicine, Chicago, IL, United States.
  • Jayathilake K; Northwestern Feinberg School of Medicine, Chicago, IL, United States.
Schizophr Res ; 154(1-3): 14-22, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24630262

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Risperidona Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Risperidona Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2014 Tipo de documento: Article